Biological mechanisms
Impact on brain function
Animal vs. human research
IF in neurodegenerative disease research
Commercial and consumer adoption
Conclusion
Intermittent fasting (IF) has gained considerable traction in both wellness communities and scientific research due to its potential to influence brain and cognitive health. Originally popularized as a dietary approach for weight management, IF now attracts interest for its broader health benefits, especially its effects on the brain.
The practice involves alternating periods of calorie restriction (CR) ranging from 12 to 48 hours with periods of normal eating. This pattern is believed to replicate ancestral human eating habits shaped by food scarcity.
Studies suggest that IF may trigger beneficial metabolic, cellular, and circadian changes that support neuroplasticity and protect against cognitive decline. Unlike calorie-restricted diets, IF can enhance brain function without requiring changes in nutrient intake.
Different IF variants, such as time-restricted eating, alternate-day fasting, and the 5:2 diet, have emerged, each offering flexibility for diverse lifestyles. As scientific interest deepens, IF is being explored not just as a health trend but as a legitimate intervention for maintaining brain health and preventing neurodegenerative disorders.1
This article examines the evidence linking IF with brain health, focusing on its effects on memory, neurogenesis, and the risk of neurological diseases.
Image Credit: Kmpzzz/Shutterstock.com
Biological mechanisms
IF exerts profound biological effects through autophagy, ketone production, and metabolic flexibility. Autophagy, a critical cellular self-recycling mechanism, is enhanced by IF through the activation of 5'-Adenosine Monophosphate-Activated Protein Kinase (AMPK) and sirtuin 1 (SIRT1) signaling pathways.
This process effectively clears damaged cellular components and supports cellular integrity, which is particularly beneficial in preventing neurodegenerative diseases and slowing aging.2
Concurrently, IF triggers metabolic shifts that increase the production of ketone bodies, especially beta-hydroxybutyrate (β-HB). These ketones serve as alternative energy sources during glucose shortage and act as signaling molecules, activating protective pathways such as nuclear factor erythroid 2-related factor 2 (Nrf2) to reduce oxidative stress and inhibiting inflammatory signals like nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB).2
Lastly, metabolic flexibility (the body's capacity to efficiently switch between glucose and fatty acid metabolism) is significantly enhanced by IF. This adaptation, driven largely by AMPK and SIRT1 signaling, optimizes mitochondrial energy production, thereby reducing the risk of metabolic disorders such as diabetes mellitus and obesity.
Collectively, these biological mechanisms highlight IF's therapeutic potential in managing metabolic dysfunction, protecting neurological health, and enhancing overall physiological resilience.2
The Science of Ultra-Processed Foods and Mental Health
Impact on brain function
IF influences brain function through multiple mechanisms, affecting cognition, mood, and brain plasticity. Clinical and animal studies highlight several cognitive benefits resulting from IF-induced metabolic shifts, notably the production of ketone bodies.
During fasting, ketone bodies like β-HB become the brain's main energy source, enhancing neuronal energy efficiency, cognitive performance, and stress resistance. IF significantly boosts Brain-Derived Neurotrophic Factor (BDNF) production, which supports neuron survival, synaptic plasticity, neurogenesis, and cognitive functions, notably learning and memory.
Enhanced BDNF levels are partly attributed to the influence of BHB, which promotes BDNF gene expression by inhibiting histone deacetylase and activating transcription factors such as nuclear factor κB.
IF also modulates mitochondrial function through increased expression of transcriptional coactivator Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α), leading to enhanced mitochondrial biogenesis and improved cognitive performance, particularly spatial memory.1,3
Additionally, IF promotes autophagy via suppression of the mechanistic Target of Rapamycin (mTOR) signaling, facilitating cellular cleansing and maintenance essential for neural health. These biological adaptations extend to mood stabilization, partly through modulation of the gut microbiota, which influences neuroinflammation and neurotransmission.
Human and animal studies further indicate that IF may improve symptoms and disease progression in neurological disorders like Alzheimer's, Parkinson's, multiple sclerosis, epilepsy, and mood disorders.
Thus, IF presents promising implications for neuroplasticity and overall brain health, warranting further exploration into optimal fasting protocols and long-term cognitive outcomes.1,3
Why fasting bolsters brain power: Mark Mattson at TEDxJohnsHopkinsUniversity
Animal vs. human research
Animal studies using murine models indicate that intermittent energy restriction (IER) independently improves β cell function, insulin secretion, and insulin resistance, irrespective of weight loss. These effects stem primarily from mechanisms involving the autophagy-lysosome pathway and the activation of neurogenin3 (Ngn3), a marker of endocrine progenitor cells.
Additionally, beneficial changes in gut microbiota composition have been observed. In contrast, human clinical data suggest that the primary benefits of IF in individuals with type 2 diabetes mellitus (T2DM) are closely linked to weight loss.
Unlike mice, human studies consistently report reductions in body weight, visceral fat, glucose, and insulin levels, with decreased insulin levels suggesting improved peripheral insulin sensitivity rather than increased insulin secretion.
Thus, while animal research highlights direct cellular and molecular benefits of IF independent of weight, human studies emphasize metabolic improvements predominantly related to weight loss, without direct evidence of β cell regeneration or enhanced insulin secretion as observed in animal models.4
IF in neurodegenerative disease research
IF and CR have become prominent areas of research in the context of neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and aging-related cognitive decline.
Animal studies strongly support the neuroprotective potential of IF and CR, demonstrating beneficial effects such as enhanced mitochondrial efficiency, increased autophagy, reduced inflammation, and improved insulin sensitivity. Despite these encouraging animal findings, human studies remain sparse, and clinical evidence is still emerging.5
In AD research, one notable study involves a fasting-mimicking diet (FMD) administered monthly over one year to individuals with mild cognitive impairment or early AD. Early results indicate this approach is feasible and safe, though the primary cognitive outcomes have not yet been published.
In the context of mild cognitive impairment (MCI), a longitudinal study found regular IF significantly improved cognitive outcomes compared to irregular or no fasting, suggesting IF may reduce cognitive decline associated with aging.5
PD research, however, currently lacks direct human trials on IF, though preclinical models suggest fasting could beneficially influence PD progression through modulation of gut microbiota and reduced neuroinflammation.
An ongoing trial, ExpoBiome, aims to address this critical research gap. Collectively, these studies underscore the promising yet preliminary status of IF in neurodegenerative disease research, highlighting the urgent need for rigorous clinical trials to confirm therapeutic effectiveness.5
The Healthy Eating Index: How Well Does Your Diet Score?
Commercial and consumer adoption
Commercial and consumer adoption of IF has accelerated with the rise of mobile health apps and integrated wellness technology. The DoFasting app, designed to support IF regimens, demonstrates how digital tools can enhance user engagement and weight loss outcomes.
In a retrospective study of 665 individuals with obesity, users who actively engaged with the app especially those using smart scales- achieved significantly greater reductions in body weight and fat mass, along with increases in muscle mass. The study found that nudging features like progress tracking, reminders, personalized goals, and gamified challenges positively influenced app adherence and results.6
Smart scales acted as effective nudging platforms, with users displaying higher activity ratios and greater weight loss compared to non-users. These tools added an element of gamification, increasing user motivation by offering more detailed progress metrics.
The study also highlighted how sustained app engagement correlates with better weight management, reinforcing the value of interactive features in digital fasting support.6,7
Alongside apps, consumer trends show a growing interest in IF-related supplements such as electrolytes, ketone blends, and metabolic boosters marketed to support energy and appetite control during fasting. Together, these digital and nutritional tools are shaping the evolving IF market, merging personalized health tracking with commercial wellness solutions.7
Conclusion
The current consensus on IF highlights its increasing global application in both clinical and preventive health contexts. Despite growing evidence supporting its health benefits- including impacts on metabolic regulation, inflammation, and aging- research has been hampered by inconsistent terminology.
This international consensus, achieved through the Delphi method involving 38 experts, establishes standardized definitions for various fasting protocols, including intermittent fasting, time-restricted eating, and fasting-mimicking diets.
These definitions aim to reduce confusion in both clinical practice and research by clarifying distinctions between terms such as modified fasting, caloric restriction, and dry fasting.
Moving forward, the consensus recommends adopting these definitions in scientific literature to enhance comparability and collaboration across studies. However, many questions remain. Future research should focus on refining fasting protocols, identifying optimal durations and calorie thresholds, and understanding individual variations in fasting responses.
A reassessment of the definitions is planned within five years, reflecting the evolving nature of fasting science and its practical applications.
References
- Gudden, J., Arias Vasquez, A., & Bloemendaal, M. (2021). The effects of intermittent fasting on brain and cognitive function. Nutrients, 13(9), 3166.
- Zhang, A., Wang, J., Zhao, Y., He, Y., & Sun, N. (2024). Intermittent fasting, fatty acid metabolism reprogramming, and neuroimmuno microenvironment: mechanisms and application prospects. Frontiers in Nutrition, 11, 1485632.
- Brocchi, A., Rebelos, E., Dardano, A., Mantuano, M., & Daniele, G. (2022). Effects of intermittent fasting on brain metabolism. Nutrients, 14(6), 1275.
- Liliana, M. H., Ziomara, M. L., Roopa, M., & Aguilar-Salinas, C. A. (2020). Intermittent Fasting as Part of the Management for T2DM: from Animal Models to Human Clinical Studies. Current Diabetes Reports, 20(4).
- Hansen, B., Roomp, K., Ebid, H., & Schneider, J. G. (2024). Perspective: The Impact of Fasting and Caloric Restriction on Neurodegenerative Diseases in Humans. Advances in Nutrition, 15(4), 100197.
- Valinskas, S., Nakrys, M., Aleknavičius, K., Jonusas, J., & Lileikienė, A. (2023). User engagement and weight loss facilitated by a mobile app: retrospective review of medical records. JMIR Formative Research, 7(1), e42266.
- Vasim, I., Majeed, C. N., & DeBoer, M. D. (2022). Intermittent fasting and metabolic health. Nutrients, 14(3), 631. https://doi.org/10.3390/nu14030631
Further Reading